Scope of Investment

The SPC may establish segregated portfolios to pursue opportunities across selected sectors and investment stages, from early-stage development to operating assets and related strategic opportunities.

Precious Metals

Focusing primarily on gold, and selectively on silver and copper, the platform may evaluate opportunities across the mining value chain.

·  Mineral Exploration: Greenfield projects, advanced exploration assets, resource delineation programs, and near-production development opportunities.

·  Mining Development and Production: Project financing, permitting, mine development, brownfield turnaround, expansion, and operating opportunities.

·  Trading and Related Opportunities: Selected physical or structured precious-metals opportunities in major international markets, subject to investment policy, applicable regulation, and internal risk limits.

Gold Trading.png


Mineral Exploration.png


Mining Development.png


Agriculture

The agriculture theme is intended to capture long-duration value creation through food security, productivity enhancement, and supply-chain modernization.

·  Exposure may include farmland, cultivation, processing, storage, distribution, and agri-technology platforms.

·  Long-term food demand, structural supply constraints, and the modernization of agricultural systems in selected regions support the strategy.

·  Priority is given to assets and operating platforms capable of generating resilient cash flow and durable real-asset value.

Agriculture 1.png


Agriculture 2.png


Agriculture 3.png


Artificial Intelligence

The AI theme focuses on enabling infrastructure and applications that can improve productivity, decision-making, and operating efficiency across multiple industries.

·  Potential opportunities include AI infrastructure, data platforms, algorithms, applied tools, automation systems, and sector-specific software solutions.

·  The investment lens emphasizes scalable use cases, commercial adoption, and durable demand rather than short-term market enthusiasm alone.

·  The platform may also evaluate technologies that can create first-order efficiency gains for real-asset industries, including natural resources and agriculture.

Artificial Intelligence 1.png


Artificial Intelligence 2.png



Environmental Protection

The environmental theme focuses on commercially viable opportunities linked to resource efficiency, remediation, and environmental services.

·  Relevant areas may include pollution control, waste and water treatment, energy-saving technologies, remediation, and related environmental solutions.

·  Global decarbonization targets, tighter environmental standards, and rising demand for sustainable operating practices support this theme.

·  The objective is to identify projects that combine measurable environmental outcomes with investable returns.

Environmental Protection 1.jpg


Environmental Protection 2.png



Life Sciences

Anchored in the broader wave of bioeconomy development, the life sciences sector presents a compelling investment opportunity. Demand is structurally resilient, regenerative medicine is entering a new innovation cycle, and strong policy support is complemented by diversified exit pathways.

· Accelerating population aging combined with rising health awareness is driving substantial unmet clinical needs in oncology, chronic diseases, and degenerative conditions, enabling the sector to transcend macroeconomic cycles.

· Clinical progress continues to emerge across frontier areas such as stem cell technologies, cell and gene therapy (CGT), and innovative pharmaceuticals. Stem cell therapies, leveraging their tissue-repair capabilities, are establishing differentiated advantages in neurodegenerative diseases and organ injury, while high-quality platform companies are building deep competitive moats.

· National policies strongly support innovation in biopharmaceuticals and regenerative medicine. Domestic and international capital markets continue to embrace biotech companies, providing multiple exit routes through IPOs, pharmaceutical M&A, and global business development (BD) licensing deals.

0.png


1.png




Loading...